Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - CASH & EQUIVALENTS
Cash & Equivalents VRDN - Viridian Therapeutics, Inc.
103 M
LAST VALUE
55.92%
2 YEAR CAGR
25.82%
5 YEAR CAGR
85.83%
10 YEAR CAGR